Operating Expenses Endring Dato
AbbVie USD 11.11B 540M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Cara Therapeutics USD 33.76M 5.51M 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
J&J USD 16.57B 435M 2023-12
Merck USD 16.56B 6.35B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
P&G USD 17.01B 904M 2023-12
Pacira USD 148.08M 1.87M 2023-12
Revance Therapeutics USD 196.07M 72.44M 2023-09
Supernus Pharmaceuticals USD 165.31M 19.57M 2023-12



Revance Therapeutics Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.